• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    XyloCor Therapeutics Dose First Patient in Phase 2b EXACT-2 Trial

    BUSINESSWIRE

    XyloCor Raises $67.5M For Gene Therapy In Cardiovascular Disease

    BUSINESSWIRE

    XyloCor Licenses Extroducer From SmartCella For XC001 Heart Delivery

    PR NEWSWIRE

    XyloCor Reports Sustained Results of Phase 2 EXACT Clinical Trial of XC001

    BUSINESSWIRE

    XyloCor reports positive data from refractory angina gene therapy trial

    CLINICAL TRIALS ARENA

    XyloCor Reports Positive Safety Results from Phase 2 EXACT Trial of XC001

    BUSINESSWIRE

    XyloCor gene therapy hits goals, paving way for pivotal trial

    FIERCE BIOTECH

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.